A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : hCT / human calcitonin

[Related PubMed/MEDLINE]
Total Number of Papers: 149
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   hCT  (>> Co-occurring Abbreviation)
Long Form:   human calcitonin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Y12 nitration of human calcitonin (hCT): A promising strategy to produce non-aggregation bioactive hCT. ---
2019 Effects of disulfide bond and cholesterol derivatives on human calcitonin amyloid formation. ---
2019 Heme prevents highly amyloidogenic human calcitonin (hCT) aggregation: A potential new strategy for the clinical reuse of hCT. ---
2019 Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog. sCT
2018 Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity. sCT
2017 Cucurbit[7]-assisted sustained release of human calcitonin from thermosensitive block copolymer hydrogel. ---
2017 Growth-incompetent monomers of human calcitonin lead to a noncanonical direct relationship between peptide concentration and aggregation lag time. sCT
2016 A dimer model of human calcitonin13-32 forms an alpha-helical structure and robustly aggregates in 50% aqueous 2,2,2-trifluoroethanol solution. ---
2016 Effect of calcium ions on human calcitonin. Possible implications for bone resorption by osteoclasts. ---
10  2015 Inhibitory effects of magnolol and honokiol on human calcitonin aggregation. Hon, Mag, MTC
11  2014 Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias. sCT
12  2013 Calcium stimulated calcitonin measurement: a procedural proposal. MTC
13  2013 Characterization of the spherical intermediates and fibril formation of hCT in HEPES solution using solid-state 13C-NMR and transmission electron microscopy. HEPES
14  2013 Investigation of factors potentially influencing calcitonin levels in the screening and follow-up for medullary thyroid carcinoma: a cautionary note. MTC, PPI
15  2013 Role of aromatic residues in amyloid fibril formation of human calcitonin by solid-state 13C NMR and molecular dynamics simulation. CT, sCT
16  2012 Knockdown of a G protein-coupled receptor through efficient peptide-mediated siRNA delivery. CPPs
17  2012 NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. EGCG
18  2011 Converting the highly amyloidogenic human calcitonin into a powerful fibril inhibitor by three-dimensional structure homology with a non-amyloidogenic analogue. phCT, sCT
19  2011 Enhanced physical stability of human calcitonin after methionine oxidation. ---
20  2010 Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. CT, MTC
21  2010 Lipid-induced calcitonin fibrillation blocks membrane interactions of a peptide antibiotic. ---
22  2009 Construction of a recombinant eukaryotic expression plasmid containing human calcitonin gene and its expression in NIH3T3 cells. ---
23  2009 Potency and tolerance of calcitonin stimulation with high-dose calcium versus pentagastrin in normal adults. ---
24  2009 Synthesis and application of peptides as drug carriers. CPP
25  2008 Calcitonin-derived peptide carriers: mechanisms and application. CPP
26  2008 Detailed analysis concerning the biodistribution and metabolism of human calcitonin-derived cell-penetrating peptides. CPP
27  2008 Generation of carrier peptides for the delivery of nucleic acid drugs in primary cells. ---
28  2006 Expression of human calcitonin by microencapsulated recombinant myoblasts. ---
29  2005 Bilayer interaction and localization of cell penetrating peptides with model membranes: a comparative study of a human calcitonin (hCT)-derived peptide with pVEC and pAntp(43-58). CPPs, pAntp
30  2005 Calcitonin-derived carrier peptides. EGFP
31  2005 Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. ---
32  2004 Cellular internalization of human calcitonin derived peptides in MDCK monolayers: a comparative study with Tat(47-57) and penetratin(43-58). ---
33  2004 Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat(47-57) through well-differentiated epithelial models. CF, CLSM, CPP, MDCK, RP
34  2004 Effect of nanomolar concentrations of sodium dodecyl sulfate, a catalytic inductor of alpha-helices, on human calcitonin incorporation and channel formation in planar lipid membranes. SDS
35  2004 Folding analysis of hormonal polypeptide calcitonins and the oxidized calcitonins using electrospray ionization mass spectrometry combined with H/D exchange. ECT, pCT, sCT
36  2004 Frequency of RET proto-oncogene mutations in patients with normal and with moderately elevated pentagastrin-stimulated serum concentrations of calcitonin. MTC, PG
37  2004 In vitro gene delivery by a novel human calcitonin (hCT)-derived carrier peptide. ---
38  2004 Metabolic cleavage of cell-penetrating peptides in contact with epithelial models: human calcitonin (hCT)-derived peptides, Tat(47-57) and penetratin(43-58). CPP, MALDI-TOF MS, MDCK
39  2004 Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy. ---
40  2004 Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR. ---
41  2004 Structure of peptide solutions: a light scattering and numerical study. HNC
42  2003 Novel daunorubicin-carrier peptide conjugates derived from human calcitonin segments. ---
43  2002 Cellular internalization of enhanced green fluorescent protein ligated to a human calcitonin-based carrier peptide. EGFP, EPL
44  2002 Conformationally constrained human calcitonin (hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt. CT
45  2002 Side-chain lactam-bridge conformational constraints differentiate the activities of salmon and human calcitonins and reveal a new design concept for potent calcitonin analogues. sCT
46  2002 [Couple production of human calcitonin and rat peptidylglycine alpha-amidation monooxygenase in insect cells]. hmCT, PAM
47  2000 Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR. ---
48  2000 Fed-batch production of recombinant human calcitonin precursor fusion protein using Staphylococcus carnosus as an expression-secretion system. ---
49  2000 In vitro metabolism of human and salmon calcitonins in rat liver and kidney evaluated by liquid chromatography-tandem mass spectrometry. sCT
50  1999 Degradation and aggregation of human calcitonin in vitro. BBM, GI, MALDI-TOF MS, RP-HPLC, SI
51  1999 Large-scale preparation of recombinant human calcitonin from a multimeric fusion protein produced in Escherichia coli. CPY, S-hCT-Leu-Arg
52  1999 Rational design, conformational studies and bioactivity of highly potent conformationally constrained calcitonin analogues. sCT
53  1999 Synthesis and Biological Activity of Human Calcitonin Analogue. sCT
54  1999 [Clinical significance of human calcitonin and gene-related peptide in the serum of myelodysplastic syndromes patients]. AML, CGRP, MDS, RIA
55  1998 Function of the rat calcitonin receptors, C1a and C1b, expressed in Xenopus oocytes. CFTR, sCT
56  1998 Permeation and pathways of human calcitonin (hCT) across excised bovine nasal mucosa. m-to-s, Peff, s to m, sCT, SMS
57  1998 Translocation of human calcitonin in respiratory nasal epithelium is associated with self-assembly in lipid membrane. ---
58  1997 Gene expression evidence indicates that nucleotides 507-513 and 1434-1440 in 16S rRNA are organized in close proximity on the Escherichia coli 30S ribosomal subunit. PAP
59  1997 Routine measurement of plasma calcitonin in nodular thyroid diseases. MTC
60  1997 [Calcitonin, a proximal-tubular-acting diuretic: lithium clearance measurements in humans]. FENa
61  1996 An expression system for the single-step production of recombinant human amidated calcitonin. ---
62  1996 Characterization of human calcitonin fibrillation in aqueous urea solution by 1H NMR spectroscopy. ---
63  1996 Human calcitonin has the same inhibitory effect on osteoclastic bone resorption by human giant cell tumor cells as salmon calcitonin. sCT
64  1996 Proteolysis of human calcitonin in excised bovine nasal mucosa: elucidation of the metabolic pathway by liquid secondary ionization mass spectrometry (LSIMS) and matrix assisted laser desorption ionization mass spectrometry (MALDI). LSIMS, MALDI, sCT
65  1995 Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. CTEM, EM
66  1995 High expression of a recombinant human calcitonin precursor peptide in Escherichia coli. ---
67  1995 Molecular cloning and functional expression of a third isoform of the human calcitonin receptor and partial characterization of the calcitonin receptor gene. ---
68  1995 Quantitative analysis of synthetic human calcitonin by liquid chromatography-mass spectrometry. micro-LC-ESI-MS
69  1995 Structural and conformational requirements for human calcitonin activity: design, synthesis, and study of lactam-bridged analogues. ---
70  1995 Study of human calcitonin fibrillation by proton nuclear magnetic resonance spectroscopy. ---
71  1994 Calcitonin inhibits testosterone and luteinizing hormone secretion through a mechanism involving an increase in cAMP production in rats. AP, cAMP, cGMP, CGRP, hCG, LH, RIA, sCT
72  1994 Effect of human calcitonin on the secretion of luteinizing hormone in orchiectomized rats. LH, ORCH
73  1994 Interfacial adsorption and aggregation associated changes in secondary structure of human calcitonin monitored by ATR-FTIR spectroscopy. ATR-FTIR
74  1993 Development and validation of an assay to measure bioactivity of human calcitonin in vitro using T47D cell membranes. ---
75  1993 Estrogen does not restore bone lost after ovariectomy in the rat. AHPrBP
76  1993 Formation of neutralizing antibodies after treatment with human calcitonin. cAMP, sCT
77  1993 Neutralizing antibodies against calcitonin. cAMP, CT, PMO, sCT
78  1993 The structure and mechanism of formation of human calcitonin fibrils. ---
79  1992 Concentration of plasma calcium in response to human calcitonin in female rats during aging. ---
80  1992 Intracolonic bioavailability of human calcitonin in man. ---
81  1992 The effect of nasal hCT on bone turnover in Paget's disease of bone--implications for the treatment of other metabolic bone diseases. SAP
82  1992 The short term effect of peripherally administered brain-gut peptides on gastric acid secretion in rats. CCK, NT, rCGRP, TRH
83  1991 A 1H NMR study of human calcitonin in solution. ---
84  1991 A study of human calcitonin in an ovarian carcinoid and ovarian cancers. ---
85  1991 Age-related differences in the hypocalcemic effect of calcitonin and calcium excretion in female rats. ---
86  1991 Autoradiographic localization of human calcitonin sensitive binding sites in rat brain. sCT
87  1991 Effect of mitogenic and hormonal stimulation on zinc transport in mixed lymphocyte cultures. hINS, hMLC, MITO, Zn
88  1991 Intranasal and intramuscular human calcitonin in female osteoporosis and in Paget's disease of bones: a pilot study. BMC, IM, SGC
89  1991 Secretion of oligomeric Val8-human calcitonin by Saccharomyces cerevisiae. ---
90  1990 Effects of parathyroid hormone and calcitonin on Na+, Cl-, K+, Mg2+ and Ca2+ transport in cortical and medullary thick ascending limbs of mouse kidney. CTAL, MTAL, PTH, Rte
91  1990 Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin. sCT
92  1990 Factors influencing the enhanced hypocalcemic action of liposome-entrapped calcitonin. CT, F-CT, L-hCT, MLV, PC, SUV
93  1990 Inhibition of the calcium pump by human parathyroid hormone-(1-34) and human calcitonin in liver plasma membranes. hPTH
94  1990 Is helodermin-like immunoreactivity in human thyroid C cells due to a salmon calcitonin-like substance? CGRP, sCT
95  1990 Shotgun concatenation of synthetic genes: construction of concatemeric human calcitonin genes. ---
96  1990 The effect of exercise on circulating immunoreactive calcitonin in men. HR, PTH
97  1989 Effects of human and salmon calcitonin on human articular chondrocytes cultivated in clusters. PG, sCT
98  1989 The effect of bile salts on the oral mucosal absorption of human calcitonin in rats. ---
99  1988 A sensitive and specific two-site enzyme-immunoassay for human calcitonin using monoclonal antibodies. EIA, ir, RIA
100  1988 Calcitonin determination by a fast and highly sensitive enzyme amplified immunoassay. MCT, RIA